Format
Extended-release tablets

Active Ingredient
Methylphenidate hydrochloride

Non-medicinal Ingredients
Colloidal anhydrous, copolymers of methacrylic acid, fumaric acid, hypromellose 2208, hypromellose 2910, lactose monohydrate, magnesium stearate, methyl methacrylate, silica, talc, and triethyl citrate.

The coating of the 18 mg tablet contains: iron oxide red, iron oxide yellow, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.

The coating of the 27 mg tablet contains: FD&C Blue #2, iron oxide black, iron oxide yellow, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.

The coating of the 36 mg tablet contains: hypromellose 2910, lactose monohydrate, titanium dioxide, and triacetin/glycerol triacetate.

The coating of the 54 mg tablet contains: iron oxide red, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.

Product Characteristics
18 mg    Yellow film coated, capsule shaped tablets imprinted with “2392” on one side
27 mg    Gray film coated, capsule shaped tablets imprinted with “2393” on one side
36 mg    White film coated, capsule shaped tablets imprinted with “2394” on one side
54 mg    Red-brown film coated, capsule shaped tablets imprinted with “2395” on one side

ACT Methylphenidate ER is a generic alternative to Concerta®

Storage and Stability Recommendations

Store between 15°C – 30°C.  Protect from moisture.

Concerta® is a trademark of Janssen Inc., Canada.
Reference: Teva Canada Limited. ACT Methylphenidate ER Product Monograph. February 14, 2024.